Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease.
Ruth Gabriela Herrera GómezMiruna GreceaClaire GalloisValérie BoigePatricia PautierBarbara PistilliDavid PlanchardDavid MalkaMichel DucreuxOlivier MirPublished in: Cancers (2022)
Bevacizumab combined with chemotherapy is safe in cancer patients with moderately active or quiescent IBD.